{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:54:15Z","timestamp":1782500055563,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772797"],"award-info":[{"award-number":["81772797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Education Commission - Gaofeng Clinical Medicine Grant Support","award":["20172007"],"award-info":[{"award-number":["20172007"]}]},{"name":"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine - \u201cGuangci Excellent Youth Training Program\u201d","award":["GCQN-2017-A18"],"award-info":[{"award-number":["GCQN-2017-A18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10549-022-06727-9","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T19:36:45Z","timestamp":1662665805000},"page":"129-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Axilla lymph node dissection can be safely omitted in patients with 1\u20132 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis"],"prefix":"10.1007","volume":"196","author":[{"given":"Weiqi","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3286-0035","authenticated-orcid":false,"given":"Xiaosong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"6727_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/annonc\/mdz235","volume":"30","author":"HJ Burstein","year":"2019","unstructured":"Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, Colleoni M, Denkert C, Piccart-Gebhart M, Regan M, Senn HJ, Winer EP, Thurlimann B (2019) Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen international consensus guidelines for the primary therapy of early breast cancer 2019. Ann Oncol 30:1541\u20131557. https:\/\/doi.org\/10.1093\/annonc\/mdz235","journal-title":"Ann Oncol"},{"key":"6727_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569\u2013575. https:\/\/doi.org\/10.1001\/jama.2011.90","journal-title":"JAMA"},{"key":"6727_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1245\/s10434-013-3200-6","volume":"21","author":"LT Dengel","year":"2014","unstructured":"Dengel LT, Van Zee KJ, King TA, Stempel M, Cody HS, El-Tamer M, Gemignani ML, Sclafani LM, Sacchini VS, Heerdt AS, Plitas G, Junqueira M, Capko D, Patil S, Morrow M (2014) Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol 21:22\u201327. https:\/\/doi.org\/10.1245\/s10434-013-3200-6","journal-title":"Ann Surg Oncol"},{"key":"6727_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10549-020-05842-9","volume":"184","author":"W Gao","year":"2020","unstructured":"Gao W, Zeng Y, Fei X, Chen X, Shen K (2020) Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis. Breast Cancer Res Treat 184:193\u2013202. https:\/\/doi.org\/10.1007\/s10549-020-05842-9","journal-title":"Breast Cancer Res Treat"},{"key":"6727_CR5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1253-3","author":"M Yi","year":"2010","unstructured":"Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L, Hunt KK (2010) Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-010-1253-3","journal-title":"Ann Surg Oncol"},{"key":"6727_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jamcollsurg.2012.09.005","volume":"216","author":"M Yi","year":"2013","unstructured":"Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KK (2013) Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population. J Am Coll Surg 216:105\u2013113. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2012.09.005","journal-title":"J Am Coll Surg"},{"key":"6727_CR7","doi-asserted-by":"publisher","first-page":"e89778","DOI":"10.1371\/journal.pone.0089778","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Mittendorf EA, Sahin AA, Yi M, Caudle A, Hunt KK, Wu Y (2014) Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database. PLoS ONE 9:e89778\u2013e89778. https:\/\/doi.org\/10.1371\/journal.pone.0089778","journal-title":"PLoS ONE"},{"key":"6727_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4048\/jbc.2018.21.e44","volume":"21","author":"J Lee","year":"2018","unstructured":"Lee J, Choi JE, Kim SJ, Lee SB, Seong MK, Jeong J, Yoon CS, Kim BK, Sun WY (2018) Comparative study between sentinel lymph node biopsy and axillary dissection in patients with one or two lymph node metastases. J Breast Cancer 21:306\u2013314. https:\/\/doi.org\/10.4048\/jbc.2018.21.e44","journal-title":"J Breast Cancer"},{"key":"6727_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10549-019-05157-4","volume":"175","author":"J Jung","year":"2019","unstructured":"Jung J, Han W, Lee ES, Jung SY, Han JH, Noh DY, Kim Y, Choi HJ, Lee JE, Nam SJ, Lee JW, Kim HJ, Um E, Kim JH, Park S, Cho YU (2019) Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort. Breast Cancer Res Treat 175:203\u2013215. https:\/\/doi.org\/10.1007\/s10549-019-05157-4","journal-title":"Breast Cancer Res Treat"},{"key":"6727_CR10","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1200\/jco.2008.19.5750","volume":"27","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, Winchester DP, Winchester DJ (2009) Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 27:2946\u20132953. https:\/\/doi.org\/10.1200\/jco.2008.19.5750","journal-title":"J Clin Oncol"},{"key":"6727_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","volume":"20","author":"M Sol\u00e1","year":"2013","unstructured":"Sol\u00e1 M, Alberro JA, Fraile M, Santesteban P, Ramos M, Fabregas R, Moral A, Ballester B, Vidal S (2013) Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000. Ann Surg Oncol 20:120\u2013127. https:\/\/doi.org\/10.1245\/s10434-012-2569-y","journal-title":"Ann Surg Oncol"},{"key":"6727_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial. Lancet Oncol 14:297\u2013305. https:\/\/doi.org\/10.1016\/s1470-2045(13)70035-4","journal-title":"Lancet Oncol"},{"key":"6727_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1245\/s10434-013-3350-6","volume":"21","author":"HS Park","year":"2014","unstructured":"Park HS, Chae BJ, Song BJ, Jung SS, Han W, Nam SJ, Youn HJ, Ko BK, Kim DW (2014) Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society. Ann Surg Oncol 21:1231\u20131236. https:\/\/doi.org\/10.1245\/s10434-013-3350-6","journal-title":"Ann Surg Oncol"},{"key":"6727_CR14","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1245\/s10434-014-3814-3","volume":"21","author":"Y Fu","year":"2014","unstructured":"Fu Y, Chung D, Cao MA, Apple S, Chang H (2014) Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer? Ann Surg Oncol 21:4109\u20134123. https:\/\/doi.org\/10.1245\/s10434-014-3814-3","journal-title":"Ann Surg Oncol"},{"key":"6727_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4174\/astr.2020.98.6.283","volume":"98","author":"BK Kim","year":"2020","unstructured":"Kim BK, Park BW, Hur MH, Lee HB, Park MH, Jeong J, Lee HJ, Lee J, Kim D, Sun WY (2020) Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes. Ann surg treat res 98:283\u2013290. https:\/\/doi.org\/10.4174\/astr.2020.98.6.283","journal-title":"Ann surg treat res"},{"key":"6727_CR16","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.4143\/crt.2018.438","volume":"51","author":"JH Joo","year":"2019","unstructured":"Joo JH, Kim SS, Son BH, Ahn SD, Jung JH, Choi EK, Ahn SH, Lee JW, Kim HJ, Ko BS (2019) Axillary lymph node dissection Does not improve post-mastectomy overall or disease-free survival among breast cancer patients with 1\u20133 positive nodes. Cancer res treat\u202f: off j Korean Cancer Assoc 51:1011\u20131021. https:\/\/doi.org\/10.4143\/crt.2018.438","journal-title":"Cancer res treat : off j Korean Cancer Assoc"},{"key":"6727_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1200\/jco.2016.71.0947","volume":"35","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: american society of clinical oncology clinical practice guideline update. J Clin Oncol 35:561\u2013564. https:\/\/doi.org\/10.1200\/jco.2016.71.0947","journal-title":"J Clin Oncol"},{"key":"6727_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/tbj.14191","volume":"27","author":"J Tseng","year":"2021","unstructured":"Tseng J, Alban RF, Siegel E, Chung A, Giuliano AE, Amersi FF (2021) Changes in utilization of axillary dissection in women with invasive breast cancer and sentinel node metastasis after the ACOSOG Z0011 trial. Breast J 27:216\u2013221. https:\/\/doi.org\/10.1111\/tbj.14191","journal-title":"Breast J"},{"key":"6727_CR19","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/sla.0000000000002440","volume":"268","author":"IGM Poodt","year":"2018","unstructured":"Poodt IGM, Spronk PER, Vugts G, van Dalen T, Peeters M, Rots ML, Kuijer A, Nieuwenhuijzen GAP, Schipper RJ (2018) Trends on axillary surgery in nondistant metastatic breast cancer patients treated between 2011 and 2015: a dutch population-based study in the ACOSOG-Z0011 and AMAROS era. Ann Surg 268:1084\u20131090. https:\/\/doi.org\/10.1097\/sla.0000000000002440","journal-title":"Ann Surg"},{"key":"6727_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10549-019-05520-5","volume":"180","author":"AB Tadros","year":"2020","unstructured":"Tadros AB, Moo TA, Stempel M, Zabor EC, Khan AJ, Morrow M (2020) Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy. Breast Cancer Res Treat 180:197\u2013205. https:\/\/doi.org\/10.1007\/s10549-019-05520-5","journal-title":"Breast Cancer Res Treat"},{"key":"6727_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1200\/jco.2005.01.5784","volume":"24","author":"CM Rudenstam","year":"2006","unstructured":"Rudenstam CM, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, Dent D, Campbell I, Bernhard J, Price KN, Castiglione-Gertsch M, Goldhirsch A, Gelber RD, Coates AS (2006) Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of international breast cancer study group trial 10\u201393. J Clin Oncol 24:337\u2013344. https:\/\/doi.org\/10.1200\/jco.2005.01.5784","journal-title":"J Clin Oncol"},{"key":"6727_CR22","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318:918\u2013926. https:\/\/doi.org\/10.1001\/jama.2017.11470","journal-title":"JAMA"},{"key":"6727_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181f08f32","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. https:\/\/doi.org\/10.1097\/SLA.0b013e3181f08f32","journal-title":"Ann Surg"},{"key":"6727_CR24","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1245\/s10434-016-5605-5","volume":"24","author":"E FitzSullivan","year":"2017","unstructured":"FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK, Babiera GV, Caudle AS, Black DM, Bedrosian I, Reyna C, Teshome M, Meric-Bernstam F, Hwang R (2017) Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy. Ann Surg Oncol 24:652\u2013659. https:\/\/doi.org\/10.1245\/s10434-016-5605-5","journal-title":"Ann Surg Oncol"},{"key":"6727_CR25","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1245\/s10434-012-2386-3","volume":"19","author":"S Milgrom","year":"2012","unstructured":"Milgrom S, Cody H, Tan L, Morrow M, Pesce C, Setton J, Rogers K, Arnold B, Eaton A, Catalano J, McCormick B, Powell S, Ho A (2012) Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment. Ann Surg Oncol 19:3762\u20133770. https:\/\/doi.org\/10.1245\/s10434-012-2386-3","journal-title":"Ann Surg Oncol"},{"key":"6727_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/tbj.14140","volume":"27","author":"DV Peristeri","year":"2021","unstructured":"Peristeri DV, Harissis HV (2021) Axillary lymph node dissection vs sentinel biopsy only among women with early-stage breast cancer and sentinel node metastasis: a systematic review and meta-analysis. Breast J 27:158\u2013164. https:\/\/doi.org\/10.1111\/tbj.14140","journal-title":"Breast J"},{"key":"6727_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10549-018-4840-9","volume":"171","author":"O Picado","year":"2018","unstructured":"Picado O, Khazeni K, Allen C, Yakoub D, Avisar E, Kesmodel SB (2018) Extent of regional lymph node surgery and impact on outcomes in patients with early-stage breast cancer and limited axillary disease undergoing mastectomy. Breast Cancer Res Treat 171:461\u2013469. https:\/\/doi.org\/10.1007\/s10549-018-4840-9","journal-title":"Breast Cancer Res Treat"},{"key":"6727_CR28","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.clon.2015.07.005","volume":"27","author":"A Goyal","year":"2015","unstructured":"Goyal A, Dodwell D (2015) POSNOC: a randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases. Clin Oncol (R Coll Radiol) 27:692\u2013695. https:\/\/doi.org\/10.1016\/j.clon.2015.07.005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"6727_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","volume":"17","author":"J de Boniface","year":"2017","unstructured":"de Boniface J, Frisell J, Andersson Y, Bergkvist L, Ahlgren J, Ryd\u00e9n L, OlofssonBagge R, Sund M, Johansson H, Lundstedt D (2017) Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial. BMC Cancer 17:379. https:\/\/doi.org\/10.1186\/s12885-017-3361-y","journal-title":"BMC Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06727-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06727-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06727-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T12:36:01Z","timestamp":1665405361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06727-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["6727"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06727-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"assertion":[{"value":"13 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Current study was reviewed and approved by independent ethical committees of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}